A P/B near 1.0x sits below Franklin Resources (1.13x) and far below T. Rowe Price (1.92x), which suggests the market is not capitalizing Invesco's QQQ franchise as a scarce, liquidity-protected license; the 10.12x forward P/E, by contrast, assumes a normalization that the negative TTM figure cannot corroborate. Investors should note the ratio table shows the price series sliding from roughly 34.9 in 2024Q3 to 30.1 in 2026Q3 while equity eroded, so the stable headline P/B may reflect a re-rating floor rather than improving fundamentals. Implied ROTCE at this multiple would need to reach mid-teens before a premium multiple appears justifiable, and current 2.5% ROE leaves a substantial gap.

The DuPont identity here is unusually thin: since NIM is effectively zero and fee income is 100.6% of revenue, ROE is simply ROA scaled by a declining leverage factor, meaning the drop in equity/assets from 0.58 to 0.49 mechanically suppresses ROE even when ROA improves. That pattern also means the ROE improvement from 0.7% in 2024Q3 to 2.5% in 2026Q3 is driven by recovering ROA rather than balance-sheet expansion, which is the healthier of the two sources but remains far below the 18.5–27% ROE posted by peer managers. The persistent gap between 1.2% ROA and negative TTM net margins suggests non-cash charges, not operating weakness alone, are suppressing reported profitability.

NIM is analytically inert for Invesco — it is an asset manager whose net interest income contributes under 1% of revenue — so any conclusion drawn from it would be misplaced; the meaningful variable is the efficiency ratio, whose dispersion from sub-20% readings to 155.2% implies that provisions and impairments are being routed through the expense base rather than smoothed. The 42.8% reading in 2026Q3, alongside operating income of $436.5M on roughly $1.9B of revenue, appears to reflect a genuinely cleaner quarter, but the prior four-quarter pattern gives insufficient basis to treat it as a durable run rate. Investors should monitor whether subsequent quarters cluster near 40–50% or revert toward the volatile historical band.

Because Invesco is a non-bank asset manager, CET1, Tier 1, and total capital ratios are not disclosed and cannot be assessed against regulatory minimums; the operative constraint is instead the equity/assets buffer, which has thinned alongside a $2.2B equity decline from $14.8B to $12.6B over the same window. A 0.49 ratio still appears substantial in absolute terms, but the direction of travel — combined with roughly $1.31B of dividends and $302M of buybacks over ten quarters — suggests capital return has proceeded while the base it is drawn from contracts. Given the securities portfolio swings and large non-cash provisions noted in prior analysis, shareholders may wish to treat the book value denominator as softer than the headline ratio implies.

The peer spread makes the diagnosis fairly clear: managers generating 18.5–27% ROE with 16–31% net margins (TROW, AMG, DHIL) command 1.9–2.9x book, while IVZ's near-zero margins and sub-3% ROE place it in the VRTS/BEN tier of low-multiple, value-assessed franchises. Some of the gap may be structural — Invesco's heavy retail distribution and pass-through fee structure structurally cap margins — but part appears cyclical, since the record $67B of net long-term inflows has not yet converted into normalized earnings. The 2.9% dividend yield also sits below BEN (4.2%) and TROW (4.9%), so Invesco does not compensate investors for the profitability shortfall through income either.